MustGrow Biologics
Logotype for MustGrow Biologics Corp

MustGrow Biologics (MGRO) investor relations material

MustGrow Biologics Status update summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for MustGrow Biologics Corp
Status update summary28 Oct, 2026

Market opportunity and positioning

  • Biologicals market expected to reach ~$20B, with mid-teens CAGR over the next ~5–8 years, within a $380B global market for chemicals, fertilizers and biologicals.

  • Consumer interest in food production and farmer demand for additional solutions are supporting biologicals’ growth across a broad range of technologies.

  • TerraMG and TerraSante are positioned as science-backed products; adoption depends on demonstrating field performance and value to growers.

  • Biologicals are framed as complementary tools in integrated pest management, alongside chemistry, seeds and fertilizers, rather than standalone solutions.

EMEA partnership and market fit

  • Europe is a priority for biologicals amid stricter regulation, fewer chemical crop-protection options and restrictions on synthetic fertilizers; high-value fruit and vegetable crops are a focus.

  • Regional consumer demand and regulatory pathways distinguish Europe from North America; local expertise and resources make Bayer a key route into EMEA markets.

  • Bayer contributes scientific testing, field validation and region-specific regulatory expertise, supporting international development and commercialization.

  • Bayer sees biologicals as part of farmers’ broader toolkit for crop protection, performance and more responsible food systems; partnerships can help scale solutions to more growers.

TerraMG evaluation and progress

  • A technical milestone confirmed TerraMG formulation compatibility with European farming practices and standard application equipment, with effective handling and application.

  • Field studies under real conditions confirmed meaningful disease control, with assessment focused on soil-borne diseases.

  • Bayer’s nearly two-year pre-partnership evaluation included lab and greenhouse tests, field trials, EU regulatory feasibility and intellectual-property assessment; the commercial agreement followed in Dec 2023.

  • Bayer highlighted TerraMG’s fit with demand for effective biological alternatives to address nematode-related crop yield and quality losses, particularly in fruits and vegetables.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next MustGrow Biologics earnings date

Logotype for MustGrow Biologics Corp
Q3 202625 Nov, 2026
MustGrow Biologics
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next MustGrow Biologics earnings date

Logotype for MustGrow Biologics Corp
Q3 202625 Nov, 2026

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Find what matters

AI across all first-party IR material. Live calls, transcripts, slides, filings.
A cited source card from Adobe's CFO alongside a list of forward-looking statements

Trust every finding

50m+ first-party documents. Every output traceable to its source.

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more
An automation set to trigger on the first published earnings document for GE Aerospace

Event-triggered research

Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.
An automation scheduled to run weekly on Mondays at 09:00

Scheduled research

Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more
A live LVMH Q2 2026 earnings call playing in Quartr

Live earnings calls

Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.
A live transcript excerpt from LVMH's Chairman and CEO Bernard Arnault

Live transcripts

Speaker-by-speaker, in real time. Searchable across every live and historical call.

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions